A potent inhibitor of seryl tRNAsynthetase, designated SB-217452 has been isolated from Streptomyces sp. ATCC 700974. The fermentation, isolation, structure elucidation and some
properties are described. SB-217452 showed inhibitory activity against both Staphylococcus aureus and rat seryl tRNA synthetases, with similar IC50 values of approximately 8 nM. The inhibitor is the serine linked nucleoside moiety of the antibiotic albomycin 82. In contrast to albomycin 52, SB-217452 showed only very weak antibacterial activity against a limited range of microorganisms. The compoundhas not been previously reported as a naturally occurring metabolite. In addition to SB-217452, albomycin S2 Fe3+ complex and the novel Al3+ complex were isolated from the fermentation. These complexes had no seryl tRNAsynthetase inhibitory activity.
Aminoacyl-tRNA synthetases catalyze one of the most critical steps in protein biosynthesis.
They attach one of twenty amino acids to one of about sixty tRNAs. Their specificities with regard to amino acids and tRNAs are responsible for the accurate primary structures of proteins.
The enzymes are essential for cell viability, and are potential targets for antibacterial agents. A program of screening for inhibitors of bacterial tRNA synthetases identified an inhibitor of seryl tRNAsynthetase (SRS) produced by a Streptomycete culture ATCC700974.
Here we report the production, isolation, identification, structure elucidation and biological properties of the novel metabolite, which proved to be related to albomycin 82. A novel metal complex of albomycin <52 was also isolated.
Materials and Methods
Assay Procedures for the Detection of SB-2 17452 The isolation of SB-217452 was monitored at all stages using the seryl tRNAsynthetase inhibition assay. pre-set buffer (pH 8.5) 50mM.
HPLG analysis was also performed, using a Waters Spherisorb ODS II 10^m column (4.6X250mm), mobile phase deionised water, flow rate 2ml/minute, and monitoring UVabsorbance at 225nm. SB-217452 had a retention time of 5.0 minutes.
Assay Procedure for the Albomycin 82 Fe3+ and Al3+
Complexes The isolation of the two complexes was monitored at all stages using an antibacterial assay.
All samples were assayed for antibiotic activity using the antibacterial fermentation profiles are shown in Graph 1.
The single addition of phosphate, ornithine or ferrous sulfate increased the production ofE. coli ESS antibacterial activity. The addition of all three supplements together was the most beneficial. After 3 days incubation, antibacterial activity was 4-fold greater than that produced by M3. The stability of this production was sustained such that after 4 days incubation the differential between M3+ supplements and M3alone was greater than 16-fold.
The supplemented M3mediumused for production of albomycin S2 Fe3+ and albomycin 82 Al3+ complexes, contained in addition to the ingredients described for SB-217452 production above: ornithine 15g, Na2HPO4
(anhydrous) 10.7g and FeSO4-7H2O 0.28 g per liter of tap water. pH was adjusted to 7.3 prior to sterilization.
50 flasks (500ml Erlenmeyer) containing 100ml each of supplemented M3mediumwere inoculated (3%) from compound.The compoundwas isolated from the culture supernatant using the procedure shown in Fig. 1 . Evaluation of the efficiency of the extraction process was carried out by measuring the SRS inhibitory activity of the product from each chromatographic step. The overall purification achieved was 1,500-fold compared to the culture sup ernatant.
Isolation ofAlbomycin <52 Fe3+ and Al3+ Complexes Supernatant from the culture grown in supplemented M3 medium, was loaded onto a Diaion HP 20 adsorption column and eluted with 20%/so-propanol. Fractions with E. coli ESS antibacterial activity were further purified on a SP Sephadex C25 cation exchange column (Na+ form), loaded at pH 2 and eluted with 0.2M NaCl at neutral pH. Active fractions were bulked and adjusted to pH 7 prior to loading onto a Biogel P2 size exclusion column, eluted with water. The metabolites were purified further on a C18 Matrex reversed phase column eluted with 15% MeOHin water, followed by preparative C18 reversed phase HPLC. The two metabolites were collected separately and both subjected to further C18 HPLC, eluting with 10%MeOHin 150mm, flow rate 1.0ml/minute). An autosampler was used to inject 5ji\ aliquots of solution. Sodium acetate (0.023 m), pH 6.0/methanol/acetonitrile was utilised for gradient elution of amino acid derivatives. Detection was carried out using a fluorescence detector, Ex. 230nm, Em. 445 nm.
Results

Structure Elucidation of SB-2 1 7452
The molecular formula was established as C^t^OcjNgSj by high-resolution fast atom bombardment mass (HRFAB-MS) and 13C NMRdata. Mass spectrometric deuteration experiments had indicated the presence of 10 exchangeable protons. The structure of SB-217452 shown in Table 1 was   deduced from COSY-45, HMQC and HMBC NMR experiments run in D2O and DMSO-<i6 (Table 1 and 2).
Physical and spectroscopic data obtained were very similar to those reported for the serine linked nucleoside moeity of albomycin <526) ( Table 3 ). The compound was subjected to acid hydrolysis followed by chiral derivatisation and chromatography with fluorescence detection, which confirmed the L-serine configuration. The retention times of reference AA-IBLC The relative stereochemistry at the four chiral centres around the five membered ring has been shown to be identical to that of the literature compound. This follows from the nOe and rOe data for the compoundin aqueous and dimethylsulphoxide-(i6 solution. A definitive nOe (and rOe) observed between HI' and H3' confirmed their syn-1,3 relationship and hence the relative stereochemistry at these two centres. Evidence for the relative stereochemistry at C4' follows from the weaker rOe's observed between HI ' and H4' as well as between H5' and H6. The relative stereochemistry at C2' therefore follows from the weak rOe observed between H2' and H5'. As albomycin 82 complexes were isolated from the same culture fermentation, and the optical rotation observed for SB-217452 is close to the optical rotation reported in the literature, we propose that the stereochemistry of the two remaining chiral centers C5' and C6' in SB-217452 is as shown in Table 3 . Oxford, and Streptococcus pyogenes CN10. Although SB-217452 is a very potent inhibitor of Staphylococcus aureus Oxford s.eryl tRNAsynthetase, whole cell antibacterial activity against this organism was very poor (MIC= 256^g/ml). Of the other organisms tested, activity was detected against the E. coli, M. catarrhalis and S. pyogenes (MIC=256 iug/ml, 8^g/ml and 16 /ig/ml respectively). The poor whole cell antibacterial activity might reflect poor penetration of SB-217452 through the cell wall without the benefit of a siderophore moiety.
Structure Elucidation of Albomycin <52
Fe3+ and Al3+ Complexes
As SB-217452 is related to albomycin <52, the possibility that the other metabolites were albomycins in the free or complexed form guided the structure elucidation work. The spectroscopic data were compared with published data on albomycins.7)
Massexperiments on metabolite A using the electrospray technique (+ve and -ve modes) gave strong molecular ions corresponding to a MW of 1045 suggesting the presence of the ferric complex of albomycin <52. Addition of oxalic acid in the sample induces decomplexation and The metabolites were analysed by X-ray energy spectroscopy, which confirmed the presence of iron and aluminum respectively in the samples.
The proposed structures for metabolites Aand B are the ferric and aluminum complexes of albomycin 82 respectively. The latter compound is novel. inhibitory activity of SB-2 17452 (Fig. 2) . Albomycin S2 has good Gram-positive and -negative antibacterial activity. The compound is actively taken up into bacterial cells via the transport system for the structurally similar iron complex, ferrichrome. Albomycin is cleaved and the antibacterial moiety is released into the cytoplasm, whereas the iron carrier moiety appears in the medium.
We propose, based on the evidence that SB-217452, the seryl linked nucleoside moiety of albomycin <52 is an inhibitor of seryl tRNA synthetase, that inhibition of seryl tRNAsynthetase could contribute to the mode of action of the albomycin family of antibiotics, after siderophore mediated transport into the bacterial cells. 
